J Feehally

Author PubWeight™ 99.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Isolated microscopic haematuria in the genitourinary clinic: the value of renal biopsy. Int J STD AIDS 1997 2.02
2 Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 2001 1.99
3 Treatment of IgA nephropathy. Kidney Int 2006 1.98
4 Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom. Diabet Med 1992 1.79
5 Glomerular disease as a cause of isolated microscopic haematuria. Q J Med 1994 1.70
6 High incidence of end-stage renal disease in Indo-Asians in the UK. QJM 1995 1.68
7 Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 1995 1.66
8 High incidence of minimal change nephrotic syndrome in Asians. Arch Dis Child 1985 1.51
9 Increased immunoglobulin A and immunoglobulin A1 cells in bone marrow trephine biopsy specimens in immunoglobulin A nephropathy. Am J Kidney Dis 1994 1.50
10 Parathyroidectomy in chronic renal failure: comparison of three operative strategies. J R Coll Surg Edinb 1996 1.44
11 Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclass. Nephrol Dial Transplant 1993 1.43
12 Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations. Nephrol Dial Transplant 1992 1.43
13 The third World Kidney Day: looking back and thinking forward. Clin Nephrol 2008 1.39
14 Plasma erythropoietin levels and acquired cystic disease of the kidney in patients receiving regular haemodialysis treatment. Br J Haematol 1991 1.38
15 Glucose polymer for ultrafiltration failure in CAPD. Lancet 1993 1.38
16 A comparison of the results of renal transplantation from non-heart-beating, conventional cadaveric, and living donors. Kidney Int 2000 1.35
17 IgA nephropathy: recent developments. J Am Soc Nephrol 2000 1.31
18 Diabetic renal disease: differences between Asian and white patients. Br Med J (Clin Res Ed) 1986 1.29
19 Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. Nephrol Dial Transplant 1997 1.21
20 Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 1998 1.19
21 Physical exercise in patients with severe kidney disease. Nephron Clin Pract 2010 1.12
22 High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991 1.10
23 IgA myeloma presenting as Henoch-Schönlein purpura with nephritis. Am J Kidney Dis 2000 1.06
24 Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J Am Soc Nephrol 1999 1.06
25 RCPE UK consensus conference statement: Management of acute kidney injury: the role of fluids, e-alerts and biomarkers. J R Coll Physicians Edinb 2013 1.02
26 Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J Clin Pathol 1996 1.00
27 Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schönlein purpura. Clin Exp Immunol 1994 1.00
28 Systemic vasculitis in the 1980s--is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis? J R Coll Physicians Lond 1990 0.99
29 Glomerular IgA deposition in liver disease. Nephrol Dial Transplant 1999 0.99
30 Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int 1986 0.98
31 Modulation of cellular immune function by cyclophosphamide in children with minimal-change nephropathy. N Engl J Med 1984 0.98
32 Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units. QJM 2005 0.96
33 Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation. J Clin Pathol 1999 0.95
34 B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy. Kidney Int 2008 0.95
35 Gm allotypes in membranous nephropathy. N Engl J Med 1983 0.94
36 Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. Kidney Int 1994 0.93
37 The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester city, UK. Br J Rheumatol 1992 0.93
38 Primary tuberculosis of the esophagus. Am J Gastroenterol 1984 0.92
39 Is chronic renal transplant rejection a non-immunological phenomenon? Lancet 1986 0.92
40 Asymptomatic microscopical haematuria. Br Med J (Clin Res Ed) 1986 0.91
41 Correcting impotence in the male dialysis patient: experience with testosterone replacement and vacuum tumescence therapy. Am J Kidney Dis 1998 0.90
42 The pathogenic role of immunoglobulin A polymers in immunoglobulin A nephropathy. Nephron 1993 0.89
43 Increased dimeric IgA-producing B cells in tonsils in IgA nephropathy determined by in situ hybridization for J chain mRNA. Clin Exp Immunol 1995 0.89
44 Outcome of acute renal failure following surgical repair of ruptured abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2000 0.89
45 Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy. Am J Kidney Dis 1999 0.89
46 Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy. Clin Exp Immunol 1992 0.88
47 Renal failure due to cholesterol embolisation. Postgrad Med J 1995 0.87
48 Henoch-Schönlein purpura with immunoglobulin A nephropathy and abnormalities of immunoglobulin A in a Wiskott-Aldrich syndrome carrier. Am J Kidney Dis 1997 0.86
49 Simultaneous in situ hybridisation of native mRNA and immunoglobulin detection by conventional immunofluorescence in paraffin wax embedded sections. J Clin Pathol 1992 0.86
50 Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible. J Intern Med 1992 0.85
51 Rate of decline in renal function in Indo-Asians and Whites with diabetic nephropathy. Diabet Med 1998 0.85
52 Iga nephropathy, antineutrophil cytoplasmic antibodies and crescentic glomerulonephritis in a patient with the Hermansky-Pudlak syndrome. Am J Nephrol 2001 0.85
53 Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy. Clin Immunol Immunopathol 1993 0.85
54 Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle-cell anaemia and renal failure. Nephrol Dial Transplant 1992 0.85
55 Recurrent acute renal failure with interstitial nephritis due to D-penicillamine. Ren Fail 1987 0.85
56 Effect of nifedipine on renal haemodynamics in an animal model of cyclosporin A nephrotoxicity. Clin Sci (Lond) 1990 0.84
57 The new Oxford Clinico-Pathological Classification of IgA nephropathy. Prilozi 2010 0.84
58 High risk acute renal failure. Q J Med 1986 0.83
59 Expression of the mucosal gamma delta T cell receptor V region repertoire in patients with IgA nephropathy. Kidney Int 1997 0.83
60 Identification of a novel Fcalpha receptor expressed by human mesangial cells. Kidney Int 2000 0.83
61 A quantitative study comparing adjustment and acceptance of illness in adults on renal replacement therapy. ANNA J 1999 0.83
62 In vitro immunoglobulin isotype suppression in immunoglobulin A nephropathy. Exp Nephrol 1994 0.82
63 Listeria monocytogenes peritonitis complicating CAPD. Perit Dial Int 1989 0.82
64 A comparative study of digoxigenin, 2,4-dinitrophenyl, and alkaline phosphatase as deoxyoligonucleotide labels in non-radioisotopic in situ hybridisation. J Clin Pathol 1997 0.82
65 Increasing frequency of adult IgA nephropathy in the UK? Lancet 1987 0.82
66 The effect of nifedipine on renal function in normotensive cyclosporin-A-treated renal allograft recipients. Nephrol Dial Transplant 1990 0.82
67 Erythropoietin and sexual dysfunction. Nephrol Dial Transplant 1997 0.81
68 Acute renal failure associated with haematological malignancies: a review of 10 years experience. Eur J Haematol 1991 0.81
69 Increased IgA and decreased IgG production by Epstein-Barr virus transformed B cells in culture in IgA nephropathy. Exp Nephrol 1994 0.81
70 The DQw7 allele at the HLA-DQB locus is associated with susceptibility to IgA nephropathy in Caucasians. Kidney Int 1991 0.81
71 The beneficial effects of oral nifedipine on cyclosporin-treated renal transplant recipients--a randomised prospective study. Transpl Int 1996 0.81
72 Elective conversion from cyclosporine to azathioprine: long-term follow-up. Transplant Proc 1987 0.81
73 The role of continuous ambulatory peritoneal dialysis in end-stage renal failure due to multiple myeloma. Am J Kidney Dis 1990 0.81
74 Early measurement of interstitial fibrosis predicts long-term renal function and graft survival in renal transplantation. Br J Surg 1996 0.80
75 A case of microscopic polyarteritis associated with antineutrophil cytoplasmic antibodies. Clin Nephrol 1987 0.80
76 Turnover of human tubular cells exposed to proteins in vivo and in vitro. Kidney Int 2001 0.80
77 Impaired IgG response to tetanus toxoid in human membranous nephropathy: association with HLA-DR3. Clin Exp Immunol 1986 0.80
78 Influence of nifedipine on interstitial fibrosis in renal transplant allografts treated with cyclosporin A. J Clin Pathol 1994 0.80
79 Recurrent proteinuria in chronic lymphocytic leukemia. Clin Nephrol 1981 0.80
80 Poorer graft survival in ethnic minorities: results from a multi-centre UK study of kidney transplant outcomes. Clin Nephrol 2011 0.80
81 Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients. Transpl Int 1992 0.79
82 Response to mucosal antigen challenge in IgA nephropathy. Exp Nephrol 1995 0.79
83 Accelerated hypertriglyceridemia in patients on continuous ambulatory peritoneal dialysis - a preventable abnormality. Int J Artif Organs 1981 0.79
84 IgA1 glycosylation and the pathogenesis of IgA nephropathy. Am J Kidney Dis 2000 0.79
85 Low antibody affinity restricted to the IgA isotype in IgA nephropathy. Clin Exp Immunol 1994 0.79
86 Origin and structure of pathogenic IgA in IgA nephropathy. Biochem Soc Trans 1997 0.78
87 Diabetes and renal failure in Indo-Asians in the UK--a paradigm for the study of disease susceptibility. Nephrol Dial Transplant 1997 0.78
88 Recovery of renal function after delayed revascularisation of acute occlusion of the renal artery. Br Med J (Clin Res Ed) 1988 0.78
89 Gut permeability in IgA nephropathy. Nephrol Dial Transplant 1990 0.78
90 Expression of T cell receptor variable region families by bone marrow gammadelta T cells in patients with IgA nephropathy. Clin Exp Immunol 2002 0.78
91 Predicting prognosis in IgA nephropathy. Am J Kidney Dis 2001 0.78
92 Familial membranous nephropathy. Br Med J (Clin Res Ed) 1984 0.78
93 Crossover comparison of intravenous and subcutaneous erythropoietin in haemodialysis patients. Nephrol Dial Transplant 1992 0.77
94 Microscopic haematuria. Role of renal biopsy is undervalued. BMJ 1994 0.77
95 Adrenal dysfunction in patients with renal amyloid. Q J Med 1990 0.76
96 Renal effects of amlodipine in normotensive renal transplant recipients. Nephrol Dial Transplant 1999 0.76
97 Towards defining antigens in human membranous nephropathy. Nephrol Dial Transplant 1992 0.76
98 Diabetes, cyclosporin nephrotoxicity, and serum creatinine concentration. Diabet Med 1991 0.75
99 Value of opinion by oral physician in diagnosing Wegener's granulomatosis. BMJ 1994 0.75
100 Acute renal failure associated with a labetalol overdose. Postgrad Med J 1990 0.75
101 eGFR and chronic kidney disease: Time to move forward. BMJ 2007 0.75
102 Does increasing haemoglobin concentration and haematocrit have a pressor effect in dialysis patients? Nephrol Dial Transplant 1989 0.75
103 Treatment of ethylene glycol poisoning with peritoneal dialysis. Br Med J (Clin Res Ed) 1982 0.75
104 Is Indian origin a risk factor in cadaveric renal transplantation? Transplant Proc 1992 0.75
105 Influence of nifedipine on cyclosporin A nephrotoxicity after unilateral nephrectomy in the spontaneously hypertensive rat. Clin Sci (Lond) 1991 0.75
106 Sezary cell lymphoma following cyclosporin immunosuppression for renal transplantation. Nephrol Dial Transplant 1991 0.75
107 Deficiency of IgG subclass antibody response to tetanus toxoid associated with high serum IgA levels in IgA nephropathy. Clin Nephrol 1993 0.75
108 The effect of the thromboxane receptor antagonist GR32191B on cyclosporine-induced nephrotoxicity. Transplant Proc 1991 0.75
109 The changing face of end stage renal disease in a UK renal unit. J R Coll Physicians Lond 1989 0.75
110 Autoantibodies in IgA nephropathy. Contrib Nephrol 1995 0.75
111 Renal transplant fibrosis: histomorphometric assessment of early renal transplant biopsies for markers of chronic rejection. Transplant Proc 1997 0.75
112 An antibody-mediated bullous skin eruption caused by chronic renal allograft rejection. Transplantation 1982 0.75
113 Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients. Nephrol Dial Transplant 1998 0.75
114 The nephritogenic immune response. Curr Opin Nephrol Hypertens 1994 0.75
115 Does low-calcium dialysate improve the nutritional status of CAPD patients? Perit Dial Int 1993 0.75
116 IgA glycosylation in IgA nephropathy. Adv Exp Med Biol 1998 0.75
117 Improved immediate graft function with nifedipine in cyclosporine-treated renal allograft recipients--a randomized prospective study. Transplantation 1992 0.75
118 Necrotising fasciitis. Lancet 1994 0.75
119 Correction of metabolic acidosis and the protein catabolic rate in PD patients. Perit Dial Int 1994 0.75
120 Urticaria, arthralgia, and nephropathy without amyloidosis: another variant of the Muckle-Wells syndrome? Clin Genet 1996 0.75
121 Calcium channel blockers and cyclosporine metabolism. Transplantation 1989 0.75
122 Management of immunosuppression in renal transplant patients with septicaemia. J R Coll Surg Edinb 1992 0.75
123 Visceral glomerular epithelial cell DNA synthesis in experimental and human membranous disease. Exp Nephrol 1998 0.75
124 Renal transplantation: nifedipine for the nonstarters? A prospective randomised study. Transplant Proc 1993 0.75
125 The nucleotide sequence of the IgA1 hinge region in IgA nephropathy. Nephrol Dial Transplant 1998 0.75
126 Nifedipine does not inhibit ciclosporin A uptake into human cultured proximal tubular cells. Nephron 1991 0.75
127 Phosphoinositide hydrolysis is not enhanced by ciclosporin. Nephron 1991 0.75
128 Adverse effects of OKT3 therapy: increased risk with impaired renal function. Transplant Proc 1994 0.75
129 Complications of using OKT3 for induction of immunosuppression in recipients of kidneys from nonheart beating donors. Transplant Proc 1994 0.75
130 Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens. Transplant Proc 1996 0.75
131 Predictors of renal function in diabetic and non-diabetic renal disease. Clin Chim Acta 1983 0.75
132 CAPD: successful use in the treatment of nephrogenic ascites. Nephrol Dial Transplant 1989 0.75
133 Treatment of steroid resistant rejection following renal transplantation: benefits and risks of OKT3 therapy. Transplant Proc 1996 0.75